Bolt Biotherapeutics, Inc. (BOLT)
5.00
-0.06
(-1.19%)
USD |
NASDAQ |
Nov 20, 10:47
Bolt Biotherapeutics Cash from Investing (Quarterly) : 4.00M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 4.00M |
| June 30, 2026 | 7.772M |
| March 31, 2026 | 7.923M |
| December 31, 2025 | 1.074M |
| September 30, 2025 | 17.88M |
| June 30, 2025 | 10.79M |
| March 31, 2025 | 14.55M |
| December 31, 2024 | 12.23M |
| September 30, 2024 | 17.14M |
| June 30, 2024 | 18.00M |
| March 31, 2024 | 10.20M |
| December 31, 2023 | 15.81M |
| September 30, 2023 | 12.66M |
| June 30, 2023 | 13.58M |
| Date | Value |
|---|---|
| March 31, 2023 | 28.99M |
| December 31, 2022 | 16.44M |
| September 30, 2022 | 1.45M |
| June 30, 2022 | -0.868M |
| March 31, 2022 | 40.84M |
| December 31, 2021 | 21.03M |
| September 30, 2021 | -16.11M |
| June 30, 2021 | -46.60M |
| March 31, 2021 | -190.52M |
| December 31, 2020 | 1.704M |
| September 30, 2020 | -13.10M |
| June 30, 2020 | 4.407M |
| March 31, 2020 | -13.61M |
| December 31, 2019 | -0.067M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Caribou Biosciences, Inc. | 19.39M |
| Oncolytics Biotech, Inc. | -0.0069M |
| Sangamo Therapeutics, Inc. | -0.013M |
| Sarepta Therapeutics, Inc. | -158.35M |
| Anixa Biosciences, Inc. | -0.245M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.078M |
| Free Cash Flow | -24.80M |
| Free Cash Flow Per Share (Quarterly) | -1.566 |
| Free Cash Flow to Equity (Quarterly) | -2.343M |
| Free Cash Flow to Firm (Quarterly) | -3.078M |
| Free Cash Flow Yield | -230.2% |